CliffBio
small molecule

POTASSIUM IODIDE

POTASSIUM IODIDE

Loss of exclusivity—loss of exclusivity
CompanyMISSION PHARMACAL CO

Drug detail

Brand namePOTASSIUM IODIDE
Active ingredientPOTASSIUM IODIDE
Strength65MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2016
Marketing statusOTC

More from MISSION PHARMACAL CO

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

POTASSIUM IODIDE patent cliff — loss of exclusivity — | CliffBio